Stay updated on ABP 959 vs Eculizumab in PNH: Clinical Trial
Sign up to get notified when there's something new on the ABP 959 vs Eculizumab in PNH: Clinical Trial page.

Latest updates to the ABP 959 vs Eculizumab in PNH: Clinical Trial page
- Check2 days agoChange DetectedA banner announces NIH website transition updates and says that, under Executive Order 14434, NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check9 days agoChange DetectedThe site revision in the footer changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check15 days agoChange DetectedThe site revision identifier in the footer changes from v3.7.0 to v3.7.1. The study record remains inaccessible behind a 403 Forbidden page.SummaryDifference0.2%

- Check36 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record with an access-denied screen. It also removes most study content and Amgen-related documents from view.SummaryDifference20%

- Check57 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6, indicating a minor software version update. No substantive changes to the study content are indicated by this change.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, representing a minor version update to the study record documentation. This change updates the metadata without altering the underlying study information or results.SummaryDifference0.0%

Stay in the know with updates to ABP 959 vs Eculizumab in PNH: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABP 959 vs Eculizumab in PNH: Clinical Trial page.